Myriad Genetics Inc (NASDAQ:MYGN)

32.70
Delayed Data
As of Feb 22
 -0.61 / -1.83%
Today’s Change
17.50
Today|||52-Week Range
41.57
-4.79%
Year-to-Date

Today’s Trading

Previous close33.31
Today’s open33.28
Day’s range32.56 - 33.51
Volume378,544
Average volume (3 months)852,604
Market cap$2.3B
Data as of 4:00pm ET, 02/22/2018

Growth & Valuation

Earnings growth (last year)-81.29%
Earnings growth (this year)+8.39%
Earnings growth (next 5 years)+9.30%
Revenue growth (last year)+2.33%
P/E ratio17.8
Price/Sales2.30
Price/Book2.93

Competitors

----
NEOGNeogen Corp-0.62-1.03%
IMMUImmunomedics Inc-0.01-0.06%
QDELQuidel Corp-2.69-5.80%
Data as of 4:15pm ET, 02/22/2018

Financials

Next reporting dateMay 2, 2018
EPS forecast (this quarter)$0.26
Annual revenue (last year)$771.4M
Annual profit (last year)$21.8M
Net profit margin2.83%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark C. Capone
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts